The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders.

F.L. van Muiswinkel; H.B. Kuiperij

The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders.

Translated title of the contribution: The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders.

F.L. van Muiswinkel, H.B. Kuiperij

Neurology & Neurosurgery

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders.
Original language	Undefined/Unknown
Pages (from-to)	267-81
Number of pages	15
Journal	Current Drug Targets. CNS and Neurological Disorders
Volume	4
Issue number	3
Publication status	Published - 2005

Cite this

@article{df242166bbe641f89acaace4b958e66f,

title = "The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders.",

author = "{van Muiswinkel}, F.L. and H.B. Kuiperij",

year = "2005",

language = "Undefined/Unknown",

volume = "4",

pages = "267--81",

journal = "Current Drug Targets. CNS and Neurological Disorders",

issn = "1568-007X",

publisher = "Bentham Science Publishers B.V.",

number = "3",

}

TY - JOUR

T1 - The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders.

AU - van Muiswinkel, F.L.

AU - Kuiperij, H.B.

PY - 2005

Y1 - 2005

M3 - Article

SN - 1568-007X

VL - 4

SP - 267

EP - 281

JO - Current Drug Targets. CNS and Neurological Disorders

JF - Current Drug Targets. CNS and Neurological Disorders

IS - 3

ER -